No stock chart data available for this company.
27 January 2023
PAION receives positive CHMP opinion recommending approval of remimazolam for the induction and maintenance of general anesthesia in adults
14 December 2022
PAION AG convenes extraordinary general meeting for capital reductions by redemption and consolidation of shares
30 November 2022
PAION AG: CEO Dr. James Phillips leaves the Company as of 30 November 2022, appointment of Supervisory Board member Gregor Siebert as member and new CEO until 30 November 2023